Jamie L. Handlos's research while affiliated with Arizona State University and other places

Publication (1)

Full-text available
Chimeric antigen receptor (CAR) T cell-based therapies have shown tremendous advancement in clinical and pre-clinical studies for the treatment of hematological malignancies, such as the refractory of pre-B cell acute lymphoblastic leukemia (B-ALL), chronic lymphocytic leukemia (CLL), and large B cell lymphoma (LBCL). However, CAR T cell therapy fo...


... Previous studies have shown that stably CAR expressing NKs can be achieved through lentiviral and retroviral expressional systems [61]. Others have also reported the use of nonviral expression systems for this purpose [62][63][64]. ...